Developer docs
API playgroundTry for free, no card

Search company profiles

Eurostars

Full company profile

uuid0006ykq

Namestring
Eurostars
Legal namestring
Eureka Network AISBL
Company typeenum
Private
Founded yearint
1985
Descriptiontext

Eurostars is a European Joint Programme operated by Eureka Network AISBL, a Belgian non-profit international association (BE 0429 585 680), that funds international collaborative R&D projects led by innovative SMEs. The programme provides co-funding via the European Union's Horizon Europe framework, with the current Eurostars-3 iteration embedded in the European Partnership on Innovative SMEs. It is supported by a network of 47 national and regional funding bodies that handle eligibility assessment, national application requirements, and grant disbursement, while consortia submit proposals through a centralised online platform (myeurekaproject.org). Maximum funding per project partner ranges from approximately €120,000 to €500,000 depending on the country, and the programme covers all technology fields.

The Eurostars offering sits within a broader Eureka portfolio that includes Innowwide, Eureka Clusters, Network Projects, Globalstars, Fast Track to the EIC Accelerator, and Investment Readiness. Beyond grant disbursement, Eurostars generates operational activity through periodic biannual calls (Call 11 deadline September 2026, Call 12 deadline March 2027), applicant webinars, success-story content, and participation in industry events such as Swiss Biotech Day. The programme is tracked to have supported 6,750 cumulative collaborative R&D projects and to have mobilised €40 billion of public-private investment across the wider Eureka Network.

Eurostars is not a commercial entity and does not generate revenue in the traditional sense. Its economics are those of a public funding instrument: capital flows in from EU Horizon Europe co-funding and national ministry contributions, and flows out as grants to approved SME-led consortia. The target applicant pool comprises innovation-driven SMEs (primary), with large companies, universities, and research organisations acting as consortium partners. As a programme, Eurostars competes not on price or product features but on funding access, partner-matching facilitation, and the credibility of EU co-financing—distributing its offering through localised national agencies and a centralised evaluation framework.

Short descriptiontext

Eurostars is a European Joint Programme, operated by Belgium-based Eureka Network AISBL, that funds international collaborative R&D projects led by innovative SMEs across 47 member countries, co-financed by the EU through Horizon Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBrussels, Belgium
HQ citystring
Brussels
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
R&D funding programme, SME innovation grants, international research collaboration, cross-border R&D financing, innovative SME support
Industry3 codes
1International Grantmaking & Development Foundations
CodeBPAGAKAHPrimaryYes
2Grantmaking & Philanthropic Funds (Institutional Donors)
CodeBPADAOABPrimaryNo
3National Development Banks & State Development Finance Institutions (DFIs)
CodeBPADACACPrimaryNo
NAICS code2 codes
  • Grantmaking Foundations813211
  • Grantmaking and Giving Services81321
SIC code3 codes
  • International Affairs9721
  • Foreign Governments8888
  • Federal & Federally-Sponsored Credit Agencies6111
Product category
Public R&D Funding Programme
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Grant disbursement
TypeLicensing Royalties
Description

Eurostars does not generate revenue as it is a public funding instrument. It disburses grant funding to eligible R&D projects through national funding bodies in participating countries. The EU co-funds the European Partnership on Innovative SMEs through Horizon Europe.

eurekanetwork.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Eurostars is a public funding instrument operated under the Eureka Network that disburses grants to support innovative SMEs and their consortium partners (large companies, universities, research organisations) in conducting international collaborative R&D projects. Projects must be led by an innovative SME from one of the 47 participating countries and can be applied for through periodic funding calls via the myeurekaproject.org platform and national funding bodies. The programme operates across all technology fields and sectors, with project funding ranging from approximately €120,000 to €500,000 per partner depending on country rules.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 6,750 collaborative international R&D projects supported
+1 more record
Product overview1 text field

Eurostars is a funding instrument and programme under the Eureka Network that supports innovative SMEs and project partners (large companies, universities, research organisations) by funding international collaborative R&D and innovation projects. The main Eurostars programme is complemented by several sub-programmes including Innowwide, Eureka Clusters, Network Projects, Fast Track to the EIC Accelerator, Globalstars, and Investment Readiness. Eurostars operates through periodic funding calls (Call 11 with September 2026 deadline, Call 12 with March 2027 deadline) where project consortia led by innovative SMEs can apply for public funding to develop products, processes, or services with commercial potential. The programme has funded various R&D projects across diverse sectors including life sciences, autonomous driving, sustainable technology, and digital solutions.

Product and service7 records
1Eurostars
CategoryCore R&D funding programme
Description

Core public funding instrument of the Eureka Network that supports innovative SMEs and their consortium partners (large companies, universities, research organisations) by funding international collaborative R&D and innovation projects across all technology fields.

2Innowwide
CategorySub-programme
Description

Sub-programme under the Eureka Network that supports international R&D and innovation projects for SMEs, large companies, universities and research organisations.

3Eureka Clusters
CategorySub-programme
Description

Funding programme that supports collaborative R&D projects within specific industry clusters and technology areas.

4Network Projects
CategorySub-programme
Description

Flexible programme for international research and development cooperation with limited eligibility criteria, allowing participation even without funding eligibility.

5Fast Track to the EIC Accelerator
CategorySub-programme
Description

Funding pathway that provides fast-track access to the European Innovation Council (EIC) Accelerator for SMEs with innovative projects.

6Globalstars
CategorySub-programme
Description

Eureka programme that supports international collaborative R&D projects with partners from specific bilateral or multilateral country partnerships.

7Investment Readiness
CategorySub-programme
Description

Programme designed to help SMEs and innovators prepare for investment by providing coaching, mentorship, and access to investors.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

InVirtuoLabs, a biotech startup, leads the €2.3M Eurostars NEUROSPARK project along with partners 7hc (Italy), INSYBIO (Greece), and oloBion (Spain). The 36-month project aims to identify and validate lead small molecules for Spinocerebellar Ataxia Type 3 using AI-based Virtual Cell Models.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

Italian partner in the NEUROSPARK Eurostars project focused on drug discovery for SCA3 using AI-based Virtual Cell Models.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

Greek partner in the NEUROSPARK Eurostars project focused on neurodegenerative disease research using AI-based digital twins.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

Spanish partner in the NEUROSPARK Eurostars project developing treatments for Spinocerebellar Ataxia Type 3.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Network of national and regional funding agencies across 47 Eureka member countries that manage national eligibility criteria, process applications, and disburse funding to approved projects.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The EIC is the EU's flagship deep-tech funding instrument for innovative SMEs and startups, operating under Horizon Europe with blended finance (grants + equity). It directly overlaps with Eurostars in target customer (innovative SMEs) and funding mechanism (public R&D grants), and the Fast Track to EIC Accelerator sub-programme creates a structural link between the two.

2Eureka Clusters Programme
TypeDirect peer
Description

Eureka Clusters is a sibling funding programme under the same Eureka Network umbrella that supports large-company-led collaborative R&D in strategic technology areas (e.g., Xecs, ITEA, Celtic). It overlaps with Eurostars in consortium-based international R&D funding but is oriented toward industry-led clusters rather than SME-led projects.

TypeRegional player
Description

Innovate UK is the United Kingdom's national innovation agency, funding business-led R&D and serving as the UK delivery partner for Eurostars. It is comparable as a public grantmaking body funding innovative SMEs, but operates domestically and does not directly compete for Eurostars' pan-European mandate.

TypeRegional player
Description

Bpifrance is France's public investment bank funding SME innovation through grants, loans, and equity. As the French national delivery body for Eurostars, it overlaps in target customer (innovative SMEs) and mission (public R&D funding), but its core mandate is domestic French innovation support.

TypeBroad incumbent
Description

The US SBIR programme is the largest federal R&D funding programme for small businesses, awarding ~$4B annually across 11 federal agencies. It is functionally comparable to Eurostars in mission (public R&D funding for innovative SMEs) and grant structure, but operates at far greater scale and within a single national jurisdiction.

TypeDirect peer
Description

The Enterprise Europe Network is an EU-co-funded programme helping SMEs access EU funding, find international partners, and understand EU regulation. It directly complements Eurostars by supporting SME internationalization and partnership formation, with overlapping target customers and EU policy alignment.

TypeRegional player
Description

CDTI is Spain's national innovation agency funding business R&D projects through grants and loans. It overlaps with Eurostars in SME R&D grantmaking and serves as Spain's Eurostars delivery body, but its core mandate is domestic Spanish innovation support.

TypeRegional player
Description

Innosuisse is the Swiss federal innovation promotion agency funding science-based innovation through industry-academia partnerships. It is comparable to Eurostars as a public R&D grantmaking body for innovative SMEs, but operates within Switzerland's national framework.

TypeRegional player
Description

Vinnova is Sweden's innovation agency funding research and innovation projects. As Sweden's Eurostars delivery body, it is comparable in mission (public R&D grantmaking for SMEs) but operates primarily within Sweden's domestic innovation ecosystem.

TypeRegional player
Description

Germany's federal ministries and agencies (including BMWK and the DLR Project Management Agency) deliver Eurostars nationally and provide parallel domestic R&D funding programmes. They overlap with Eurostars in target customer (innovative SMEs) and grantmaking function but are primarily domestic in scope.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment113 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eurostars

Public R&D Funding Programmeeurekanetwork.org

Eurostars is a European Joint Programme, operated by Belgium-based Eureka Network AISBL, that funds international collaborative R&D projects led by innovative SMEs across 47 member countries, co-financed by the EU through Horizon Europe.

What Eurostars does

Eurostars is a European Joint Programme operated by Eureka Network AISBL, a Belgian non-profit international association (BE 0429 585 680), that funds international collaborative R&D projects led by innovative SMEs. The programme provides co-funding via the European Union's Horizon Europe framework, with the current Eurostars-3 iteration embedded in the European Partnership on Innovative SMEs. It is supported by a network of 47 national and regional funding bodies that handle eligibility assessment, national application requirements, and grant disbursement, while consortia submit proposals through a centralised online platform (myeurekaproject.org). Maximum funding per project partner ranges from approximately €120,000 to €500,000 depending on the country, and the programme covers all technology fields.

The Eurostars offering sits within a broader Eureka portfolio that includes Innowwide, Eureka Clusters, Network Projects, Globalstars, Fast Track to the EIC Accelerator, and Investment Readiness. Beyond grant disbursement, Eurostars generates operational activity through periodic biannual calls (Call 11 deadline September 2026, Call 12 deadline March 2027), applicant webinars, success-story content, and participation in industry events such as Swiss Biotech Day. The programme is tracked to have supported 6,750 cumulative collaborative R&D projects and to have mobilised €40 billion of public-private investment across the wider Eureka Network.

Eurostars is not a commercial entity and does not generate revenue in the traditional sense. Its economics are those of a public funding instrument: capital flows in from EU Horizon Europe co-funding and national ministry contributions, and flows out as grants to approved SME-led consortia. The target applicant pool comprises innovation-driven SMEs (primary), with large companies, universities, and research organisations acting as consortium partners. As a programme, Eurostars competes not on price or product features but on funding access, partner-matching facilitation, and the credibility of EU co-financing—distributing its offering through localised national agencies and a centralised evaluation framework.

Eurostars firmographics

Firmographics
Name
Eurostars
Legal name
Eureka Network AISBL
Website
https://eurekanetwork.org
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
101–250 employees
Short description
Eurostars is a European Joint Programme, operated by Belgium-based Eureka Network AISBL, that funds international collaborative R&D projects led by innovative SMEs across 47 member countries, co-financed by the EU through Horizon Europe.
Ownership category
akta.pro rank

Eurostars industry classification

Industry
Product category
Public R&D Funding Programme
NAICS
Grantmaking Foundations (813211), Grantmaking and Giving Services (81321)
SIC
International Affairs (9721), Foreign Governments (8888), Federal & Federally-Sponsored Credit Agencies (6111)
akta.pro primary industry
International Grantmaking & Development Foundations (BPAGAKAH)
akta.pro secondary industries
Grantmaking & Philanthropic Funds (Institutional Donors) (BPADAOAB), National Development Banks & State Development Finance Institutions (DFIs) (BPADACAC)

Keywords

  • R&D funding programme
  • SME innovation grants
  • International research collaboration
  • Cross-border R&D financing
  • Innovative SME support

Where Eurostars is headquartered

Location

Headquarters

HQ city
Brussels
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

Eurostars business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Grant disbursement: Eurostars does not generate revenue as it is a public funding instrument. It disburses grant funding to eligible R&D projects through national funding bodies in participating countries. The EU co-funds the European Partnership on Innovative SMEs through Horizon Europe.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Eurostars product offering

Product offering

Core offering

Eurostars is a public funding instrument operated under the Eureka Network that disburses grants to support innovative SMEs and their consortium partners (large companies, universities, research organisations) in conducting international collaborative R&D projects. Projects must be led by an innovative SME from one of the 47 participating countries and can be applied for through periodic funding calls via the myeurekaproject.org platform and national funding bodies. The programme operates across all technology fields and sectors, with project funding ranging from approximately €120,000 to €500,000 per partner depending on country rules.

Product overview

Eurostars is a funding instrument and programme under the Eureka Network that supports innovative SMEs and project partners (large companies, universities, research organisations) by funding international collaborative R&D and innovation projects. The main Eurostars programme is complemented by several sub-programmes including Innowwide, Eureka Clusters, Network Projects, Fast Track to the EIC Accelerator, Globalstars, and Investment Readiness. Eurostars operates through periodic funding calls (Call 11 with September 2026 deadline, Call 12 with March 2027 deadline) where project consortia led by innovative SMEs can apply for public funding to develop products, processes, or services with commercial potential. The programme has funded various R&D projects across diverse sectors including life sciences, autonomous driving, sustainable technology, and digital solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Eurostars Core public funding instrument of the Eureka Network that supports innovative SMEs and their consortium partners (large companies, universities, research organisations) by funding international collaborative R&D and innovation projects across all technology fields.
  • Innowwide Sub-programme under the Eureka Network that supports international R&D and innovation projects for SMEs, large companies, universities and research organisations.
  • Eureka Clusters Funding programme that supports collaborative R&D projects within specific industry clusters and technology areas.
  • Network Projects Flexible programme for international research and development cooperation with limited eligibility criteria, allowing participation even without funding eligibility.
  • Fast Track to the EIC Accelerator Funding pathway that provides fast-track access to the European Innovation Council (EIC) Accelerator for SMEs with innovative projects.
  • Globalstars Eureka programme that supports international collaborative R&D projects with partners from specific bilateral or multilateral country partnerships.
  • Investment Readiness Programme designed to help SMEs and innovators prepare for investment by providing coaching, mentorship, and access to investors.

Quantifiable outcome

  • 6,750 collaborative international R&D projects supported
  • +1 more outcomes

Companies that use Eurostars

Customer profile

Segments3 records

Ideal customer profiles3 records

Eurostars technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Eurostars partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • InVirtuoLabsminorStrategic or Co-development Partner · 11 February 2026InVirtuoLabs, a biotech startup, leads the €2.3M Eurostars NEUROSPARK project along with partners 7hc (Italy), INSYBIO (Greece), and oloBion (Spain). The 36-month project aims to identify and validate lead small molecules for Spinocerebellar Ataxia Type 3 using AI-based Virtual Cell Models.
  • 7hc (Italy)minorStrategic or Co-development Partner · 11 February 2026Italian partner in the NEUROSPARK Eurostars project focused on drug discovery for SCA3 using AI-based Virtual Cell Models.
  • INSYBIO (Greece)minorStrategic or Co-development Partner · 11 February 2026Greek partner in the NEUROSPARK Eurostars project focused on neurodegenerative disease research using AI-based digital twins.
  • oloBion (Spain)minorStrategic or Co-development Partner · 11 February 2026Spanish partner in the NEUROSPARK Eurostars project developing treatments for Spinocerebellar Ataxia Type 3.
  • National Funding Bodies (47 countries)coreChannel Partner/ Reseller/ DistributorNetwork of national and regional funding agencies across 47 Eureka member countries that manage national eligibility criteria, process applications, and disburse funding to approved projects.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Eurostars competitors and assessment

Company assessment

Direct peers

  • European Innovation Council (EIC): The EIC is the EU's flagship deep-tech funding instrument for innovative SMEs and startups, operating under Horizon Europe with blended finance (grants + equity). It directly overlaps with Eurostars in target customer (innovative SMEs) and funding mechanism (public R&D grants), and the Fast Track to EIC Accelerator sub-programme creates a structural link between the two.
  • Eureka Clusters Programme: Eureka Clusters is a sibling funding programme under the same Eureka Network umbrella that supports large-company-led collaborative R&D in strategic technology areas (e.g., Xecs, ITEA, Celtic). It overlaps with Eurostars in consortium-based international R&D funding but is oriented toward industry-led clusters rather than SME-led projects.
  • Enterprise Europe Network (EEN): The Enterprise Europe Network is an EU-co-funded programme helping SMEs access EU funding, find international partners, and understand EU regulation. It directly complements Eurostars by supporting SME internationalization and partnership formation, with overlapping target customers and EU policy alignment.

Regional players

  • Innovate UK: Innovate UK is the United Kingdom's national innovation agency, funding business-led R&D and serving as the UK delivery partner for Eurostars. It is comparable as a public grantmaking body funding innovative SMEs, but operates domestically and does not directly compete for Eurostars' pan-European mandate.
  • Bpifrance: Bpifrance is France's public investment bank funding SME innovation through grants, loans, and equity. As the French national delivery body for Eurostars, it overlaps in target customer (innovative SMEs) and mission (public R&D funding), but its core mandate is domestic French innovation support.
  • CDTI (Centro para el Desarrollo Tecnológico Industrial): CDTI is Spain's national innovation agency funding business R&D projects through grants and loans. It overlaps with Eurostars in SME R&D grantmaking and serves as Spain's Eurostars delivery body, but its core mandate is domestic Spanish innovation support.
  • Innosuisse: Innosuisse is the Swiss federal innovation promotion agency funding science-based innovation through industry-academia partnerships. It is comparable to Eurostars as a public R&D grantmaking body for innovative SMEs, but operates within Switzerland's national framework.
  • Vinnova: Vinnova is Sweden's innovation agency funding research and innovation projects. As Sweden's Eurostars delivery body, it is comparable in mission (public R&D grantmaking for SMEs) but operates primarily within Sweden's domestic innovation ecosystem.
  • Federal Ministry for Economic Affairs and Energy (BMWK) - German Eurostars Delivery: Germany's federal ministries and agencies (including BMWK and the DLR Project Management Agency) deliver Eurostars nationally and provide parallel domestic R&D funding programmes. They overlap with Eurostars in target customer (innovative SMEs) and grantmaking function but are primarily domestic in scope.

Broad incumbents

  • SBIR (Small Business Innovation Research): The US SBIR programme is the largest federal R&D funding programme for small businesses, awarding ~$4B annually across 11 federal agencies. It is functionally comparable to Eurostars in mission (public R&D funding for innovative SMEs) and grant structure, but operates at far greater scale and within a single national jurisdiction.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Eurostars social profiles

Digital presence

Eurostars financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eurostars leadership team

Management profile

Number of profiles

Eurostars funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eurostars M&A and investment

M&A and investment

M&A

Investments113 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurostars

What does Eurostars do?

Eurostars is a public funding instrument operated under the Eureka Network that disburses grants to support innovative SMEs and their consortium partners (large companies, universities, research organisations) in conducting international collaborative R&D projects. Projects must be led by an innovative SME from one of the 47 participating countries and can be applied for through periodic funding calls via the myeurekaproject.org platform and national funding bodies. The programme operates across all technology fields and sectors, with project funding ranging from approximately €120,000 to €500,000 per partner depending on country rules.

Is Eurostars a public or private company?

Eurostars is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Eurostars founded?

Eurostars was founded in 1985. It employs 101 to 250 people.

Where is Eurostars based?

Eurostars is headquartered in Brussels, Belgium, in the Europe region.

How does Eurostars make money?

One revenue line is on record: grant disbursement.

Who are Eurostars's main competitors?

Direct peers on record are European Innovation Council (EIC), Eureka Clusters Programme and Enterprise Europe Network (EEN). Regional players are Innovate UK, Bpifrance, CDTI (Centro para el Desarrollo Tecnológico Industrial), Innosuisse, Vinnova and Federal Ministry for Economic Affairs and Energy (BMWK) - German Eurostars Delivery. SBIR (Small Business Innovation Research) is listed as a broad incumbent.

Does Eurostars have an API?

No public API is recorded for Eurostars.

What industry is Eurostars in?

Eurostars's product category is Public R&D Funding Programme. Its primary akta.pro industry code is BPAGAKAH, International Grantmaking & Development Foundations, with a secondary code of BPADAOAB, Grantmaking & Philanthropic Funds (Institutional Donors). Its NAICS code is 813211 and its SIC code is 9721.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
startupticker.chInVirtuoLabs to lead €2.3M Eurostars grant project NEUROSPARKInVirtuoLabs, a biotech startup, along with partners 7hc (Italy), INSYBIO (Greece), and oloBion (Spain), has been awarded a €2.3 million Eurostars grant for the 36-month NEUROSPARK project. The research aims to identify and validate 3–5 lead small molecules for Spinocerebellar Ataxia Type 3 (SCA3), a rare neurodegenerative movement disorder, using AI-based Virtual Cell Models as digital twins of diseased cells. The project marks a strategic milestone for InVirtuoLabs, representing its shift from platform development toward validated drug discovery, with potential expansion into Alzheimer’s and Parkinson’s treatments.GlobeNewswireRenovaroCube Receives Approval of Lumina Project by the Eurostars Funding ProgramRenovaroCube and its consortium partners received Eurostars grant funding approval for the Lumina project, an AI-driven minimal residual disease detection platform for lung cancer. The project aims to improve recurrence risk prediction and treatment strategies, addressing the fact that 60% of curatively treated lung cancer patients relapse.SpringerLinkDeploying Machine Learning in High Pressure Resin Transfer Molding and Part Post Processing: A Case StudyThe Eurostars project 'Predator' has developed an intelligent data processing system to bridge the gap in high-pressure resin transfer molding (HP-RTM) composite production by integrating data from molding to post-processing. This approach enables unique part traceability, tool wear monitoring, and predictive maintenance through the collection of sensor and sound data across the industrial process chain. Preliminary results from experimental campaigns demonstrate that data-centric machine learning models significantly improve the accuracy of predicting equipment degradation compared to conventional physical modeling.HermixHermix wins 920k Euro grant from Eureka Eurostars, with the University of LuxembourgHermix has secured a 920,000 Euro grant from the Eureka Eurostars program to develop 'Hermix-Grants,' an AI-driven IT platform designed to help researchers and businesses navigate European funding opportunities. The project is being implemented in partnership with the University of Luxembourg, which will provide technical coordination and research expertise. This initiative aims to automate data analysis and simplify access to public grants through big-data integration.bionity.comVandria awarded €3.8M in prestigious Innosuisse and Eurostars grantsVandria SA has been awarded two grants totaling €3.8M from Innosuisse and Eurostars to support the development of its lead drug candidates for CNS and muscle diseases. The funding will finance the early clinical development of VNA-318 for cognitive impairments and pre-clinical data generation for VNA-052 in collaboration with French and Dutch research partners.BioSpaceVandria Awarded €3.8M in Prestigious Innosuisse and Eurostars Grants to Advance Innovative Drug Programs for Age-Related Diseases of the CNS and MuscleVandria SA has been awarded two grants totaling €3.8M from Innosuisse and Eurostars to support the clinical development of its lead drug candidates VNA-318 for CNS diseases and VNA-052 for muscle diseases. The funding includes a CHF 2.5M grant from Innosuisse for early clinical trials of VNA-318 and an €1.1M Eurostars grant to generate pre-clinical data for VNA-052 in collaboration with French and Dutch partners. This financial support validates Vandria's scientific approach as it transitions into a clinical-stage company.GlobeNewswireVandria Awarded €3.8M in Prestigious Innosuisse and Eurostars Grants to Advance Innovative Drug Programs for Age-Related Diseases of the CNS and MuscleVandria SA has been awarded €3.8M in grants from Innosuisse and Eurostars to support the clinical development of its lead drug candidates VNA-318 for CNS diseases and VNA-052 for muscle diseases. The funding includes CHF 2.5M from Innosuisse for early clinical trials of VNA-318 and €1.1M from Eurostars for pre-clinical data generation on VNA-052 in collaboration with French and Dutch partners.Empresas de Capital Riesgo en EspaRenalyse has successfully closed an investment round of 1 M€ led by Mind the Gap and with participation from GENESIS Ventures and the Eurostars programRenalyse, also known as CreatSens Health, has secured an investment round of 1 M€ led by the Mind the Gap program, with contributions from GENESIS Ventures and the Eurostars program. The funding will be used for the industrialization and certification of a diagnostic device for chronic kidney disease, enabling market entry by 2026. The device aims to allow patients to remotely monitor their health and potentially prevent severe complications from kidney disease.GlobeNewswireGain Therapeutics Announces Grant Award by Eurostars with Innosuisse for Alpha-1 Antitrypsin Deficiency Research ProgramGain Therapeutics announced a €1.2 million grant from Eurostars and Innosuisse for a consortium to develop small molecule allosteric regulators for Alpha-1 Antitrypsin Deficiency. The project includes IRB, Newcells Biotech, and the University of Helsinki, aiming to test lead molecules in in vivo models.GlobeNewswireImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel Therapeutic Antibody to Treat Inflammatory Rheumatic DiseasesImmunOs Therapeutics AG received public funding from Eurostars-2 and Innosuisse for developing a novel HLA-open conformer-specific antibody to treat chronic inflammatory rheumatic diseases. The consortium with ProteoGenix and Amsterdam UMC plans to show proof-of-concept in spondyloarthritis, targeting a mechanism that only 30-50% of current therapies address.